SDIC
South Dakota Investment Council Portfolio holdings
AUM
$5.22B
1-Year Return
11.75%
This Quarter Return
+14.09%
1 Year Return
+11.75%
3 Year Return
+59.88%
5 Year Return
+138.34%
10 Year Return
+253.47%
AUM
$4.73B
AUM Growth
+$751M
(+19%)
Cap. Flow
+$247M
Cap. Flow
% of AUM
5.23%
Top 10 Holdings %
Top 10 Hldgs %
21.47%
Holding
660
New
50
Increased
294
Reduced
83
Closed
63
Top Buys
| 1 |
Humana
HUM
|
+$19.6M |
| 2 |
Microsoft
MSFT
|
+$16.7M |
| 3 |
Accenture
ACN
|
+$16.7M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$15.3M |
| 5 |
Amazon
AMZN
|
+$14.7M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$133M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$41M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$16.2M |
| 4 |
Elevance Health
ELV
|
+$12.4M |
| 5 |
Union Pacific
UNP
|
+$7.81M |
Sector Composition
| 1 | Financials | 16.09% |
| 2 | Healthcare | 14.14% |
| 3 | Technology | 13.67% |
| 4 | Energy | 9.77% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Ovintiv
OVV
$10.9B
| $248K | 0.01% |
+6,840
| New | +$248K |
|
552
Coterra Energy
CTRA
$18.6B
| $232K | ﹤0.01% |
8,900
| – | – |
|
553
B&G Foods
BGS
$369M
| $227K | ﹤0.01% |
9,300
+5,200
| +127% | +$127K |
|
554
LivaNova
LIVN
$3.13B
| $224K | ﹤0.01% |
2,300
+1,100
| +92% | +$107K |
|
555
SpartanNash
SPTN
$898M
| $216K | ﹤0.01% |
13,600
-39,234
| -74% | -$623K |
|
|
TCO
556
DELISTED
Taubman Centers Inc.
TCO
| $212K | ﹤0.01% |
4,000
| – | – |
|
557
Regenxbio
RGNX
$479M
| $206K | ﹤0.01% |
3,600
| – | – |
|
558
Avista
AVA
$2.96B
| $203K | ﹤0.01% |
5,000
| – | – |
|
559
Ametek
AME
$44.4B
| $199K | ﹤0.01% |
2,400
| – | – |
|
560
Medpace
MEDP
$14B
| $189K | ﹤0.01% |
+3,200
| New | +$189K |
|
561
Medifast
MED
$153M
| $186K | ﹤0.01% |
+1,460
| New | +$186K |
|
562
Universal Corp
UVV
$1.4B
| $180K | ﹤0.01% |
3,116
| – | – |
|
|
PGNX
563
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $173K | ﹤0.01% |
37,200
+28,000
| +304% | +$130K |
|
564
Varex Imaging
VREX
$477M
| $159K | ﹤0.01% |
4,700
| – | – |
|
565
Nektar Therapeutics
NKTR
$898M
| $158K | ﹤0.01% |
313
| – | – |
|
566
Fortune Brands Innovations
FBIN
$7.29B
| $157K | ﹤0.01% |
3,861
| – | – |
|
567
NeoGenomics
NEO
$1.08B
| $149K | ﹤0.01% |
+7,300
| New | +$149K |
|
|
TRHC
568
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $141K | ﹤0.01% |
+2,500
| New | +$141K |
|
|
MNTA
569
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $141K | ﹤0.01% |
9,701
| – | – |
|
570
REX American Resources
REX
$1.02B
| $137K | ﹤0.01% |
5,100
| – | – |
|
571
Calavo Growers
CVGW
$496M
| $126K | ﹤0.01% |
+1,500
| New | +$126K |
|
572
Innoviva
INVA
$1.22B
| $126K | ﹤0.01% |
9,000
| – | – |
|
573
Cross Country Healthcare
CCRN
$415M
| $123K | ﹤0.01% |
17,500
-19,500
| -53% | -$137K |
|
574
Vanda Pharmaceuticals
VNDA
$272M
| $118K | ﹤0.01% |
6,400
| – | – |
|
|
NTUS
575
DELISTED
Natus Medical Inc
NTUS
| $107K | ﹤0.01% |
4,200
| – | – |
|